CancerFree Biotech
PrivateLast Round
Accelerator
Jul 1, 2023
Total Funding Raised
$1.11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CancerFree Biotech is a biotechnology company that provides a circulating tumor cell-derived organoid platform designed to predict patient responses to cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CancerFree Biotech Comparables
Compare CancerFree Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pear Bio | 79% | |
| OnconiX AG | 78% | |
| Orakl Oncology | 77% |
CancerFree Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2023 | ||||
| Seed | Nov 8, 2022 | ||||
| Accelerator | Sep 28, 2021 | ||||
| Grant | Aug 1, 2020 |
Key People
Founding team and executive leadership
CancerFree Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taipei City Government | Grant |
| Berkeley SkyDeck | Accelerator |
| Sustainable Impact Capital | Seed |
| Draper Associates | Seed |
| Taipei Medical University | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 88% MoM, reaching 3.2K.
- Mar 1, 2026
Monthly visitors increased 67% MoM.
CancerFree Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CancerFree Biotech's valuation, stock price, and market status.
Is CancerFree Biotech a public or private company?
CancerFree Biotech is a private company.
What is the current stock price of CancerFree Biotech?
CancerFree Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is CancerFree Biotech worth (valuation)?
Valuation information for CancerFree Biotech is not publicly available.
Can I buy CancerFree Biotech stock?
CancerFree Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CancerFree Biotech's last funding round?
CancerFree Biotech's most recent funding round was Accelerator on July 1, 2023.
Who are the main investors in CancerFree Biotech?
Key investors in CancerFree Biotech include Taipei City Government, Berkeley SkyDeck, Sustainable Impact Capital, Draper Associates, Taipei Medical University.
Will CancerFree Biotech IPO soon?
No public IPO plans have been announced for CancerFree Biotech.
How can I track CancerFree Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CancerFree Biotech's secondary market activity and sign up for updates.